Sionna Therapeutics, Inc.
SION
$42.18
-$0.59-1.38%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -85.57M | -75.27M | -70.68M | -75.84M | -66.32M |
| Total Depreciation and Amortization | 642.00K | 647.00K | 662.00K | 642.00K | 661.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 15.93M | 10.98M | 7.78M | 13.97M | 12.17M |
| Change in Net Operating Assets | -2.86M | -2.65M | 786.00K | -2.69M | -2.41M |
| Cash from Operations | -71.85M | -66.30M | -61.45M | -63.91M | -55.90M |
| Capital Expenditure | -291.00K | -377.00K | -200.00K | -113.00K | -113.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 47.56M | -118.37M | -125.91M | -138.69M | -144.07M |
| Cash from Investing | 47.27M | -118.75M | -126.11M | -138.80M | -144.18M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 5.85M | 206.02M | 204.39M | 202.49M | 202.53M |
| Repurchase of Common Stock | -312.00K | -312.00K | -312.00K | -312.00K | -- |
| Issuance of Preferred Stock | -- | -- | 0.00 | 0.00 | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -320.00K | -- | -1.43M | -2.50M | -2.50M |
| Cash from Financing | 5.21M | 205.71M | 202.64M | 199.67M | 200.02M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -19.37M | 20.66M | 15.08M | -3.04M | -57.00K |